Pierre Guermonprez

3PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 30, 2025
Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity.

Louise Gorline, Fillipe Luiz Rosa do Carmo, Pierre Bourdely

|Mar 14, 2024
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors.

Lucía López, Luciano Gastón Morosi, Federica La Terza

|Apr 15, 2021
TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses.

Nicoletta Caronni, Giulia Maria Piperno, Francesca Simoncello

Pageof 1